PROGRAM
-
09:30-13:30 LOCAL PROGRAM. CARDIO 1, 2, 3 PLUS. ADVANCED MEDICAL SIMULATION WORKSHOPS!
Coordinator: José María García Acuña
Simultaneous workshops:
- ECMO
Room Castelao
Marta Ruiz (Santander, Spain)
Virginia Burgos (Santander, Spain)
Sergio Santos (Santander, Spain)
Inmaculada García-Montesinos (Santander, Spain) - Pulmonary echography
Room Anatomía
Albert Duran (Barcelona, Spain)
Wlalter Bragagni (Barcelona, Spain) - Advanced Cardio-pulmonary resuscitation
Room Habilidades
Lucia Rioboo (Vigo, Spain)
Cristina González-Cambeiro (Pontevedra, Spain)
Antonela Lukic (Zaragoza, Spain)
Montserrat Vila (Barcelona, Spain) - Central iv lines
Room 1
Jordi Bañeras (Barcelona, Spain)
14:00-15:00 Lunch 15:00-16:00 CONTROVERSY FROM BOTH SIDES OF ATLANTIC: “CLINICAL TRIALS: LIGHTS AND SHADOWS”
Chairs: Héctor Bueno and Antonio Fernández-Ortiz
- "Lessons from a Trialist: A Critique of some recent Cardiology Trials"
Stuart Pocock (London, UK) - "Perspectives on trials of coronary revascularization for stable CAD".
Bernard Gersch (Rochester, USA)
16:00-17:00 UPDATE I
“Update in management of anticoagulant therapy in patients with Atrial Fibrillation”
Chairs: Inmaculada Roldán and José Luis Ferreiro
Speakers:
- Questions and answers about combination of antiplatelet and anticoagulant therapy in patients with ischemic heart disease.
Dominick Angiolillo (Jacksonville, USA) - Perioperative and periprocedural management of anticoagulant therapy.
David Vivas (Madrid, Spain) - Spanish results of the GARFIELD registry.
Xavier Viñolas (Barcelona, Spain)
17:00-17:30 Coffee break 17:30-18:30 UPDATE II
DIABETES AND ISCHAEMIC HEART DISEASE IN 2018: IT’S TIME FOR CARDIOOGIST TO GIVE A STEP FORWARD
Chair: José R. González Juanatey
- How I do It? Revascularization in diabetics with acute coronary syndromes and multivessel disease.
Belen Cid (Santiago de Compostela, Spain) - Selection of antithrombotic treatment and secondary prevention.
Alfredo Bardaji (Tarragona, Spain) - Cardiovascular safety of oral antidiabetic therapy. Current reccomendations in diabetics with ischaemic heart disease.
José R. González Juanatey (Santiago de Compostela, Spain) - Acute coronary syndromes in diabetic patients. The case for continuity of care.
Almudena Castro (Madrid, Spain)
18:30-19:30 “MAGDA HERAS” LECTURE. OPENING CONFERENCE
Chairs: Alessandro Sionis and Rosa-Maria Lidón
“Innovative approaches to the future management of CHF”.
Bernard Gersh (Rochester, USA)19:30-20:00 OPENING CEREMONY - ECMO
-
08:30-10:00 THE 2017 ESC GUIDELINES: A BACKSTAGE LOOK
Chairs: Borja Ibáñez and Héctor Bueno
- STEMI.
Borja Ibáñez (Madrid, Spain) - DAPT.
Francesco Costa (Milan, Italy) - Valve Disease.
Pilar Tornos (Barcelona, Spain)
10:00-10:45 CURRENT CHALLENGES IN ACUTE ENDOCARDITIS MANAGEMENT: DIALOGUE WITH THE EXPERTS
Chairs: Alberto San Román and Alberto Forteza
Speakers:
Pilar Tornos (Barcelona, Spain)
Eduard Quintana (Barcelona, Spain)10:45-11:15 Coffee break 11:15-12:15 COMPLEX SCENARIOS IN CORONARY REVASCULARIZATION
Chairs: José M. de la Torre Hernández and Jaime Aboal
- “Revascularization in stable CAD: waiting for the ultimate trial ".
Adnan Kastrati (Munich, Germany) - “How to individualize DAPT duration after PCI in ACS: the PRECISE DAPT score”.
Francesco Costa (Milan, Italy) - “Revascularization in patients with STEMI and multivessel disease”.
Adnan Kastrati (Munich, Germany)
12:15-13:15 UPDATE III
Atherosclerosis a global pathology: Raiders of the lost treatment
Chair: Rosa- Maria Lidón
- Prescribed therapy in real world
Alberto Cordero (Alicante, Spain) - How to improve therapeutic adherence in the patient with stroke
Jaime Masjuna (Madrid, Spain) - In ischemic heart disease patients, what does the polypill give us?
Antonio Fernández Ortiz (Madrid, Spain)
13:30-14:30 Lunch
LUNCH WITH THE LEGENDS (ahead booking required)
Hotel Monumento San Francisco
- Table 1: Susanna Price (London, UK) and Héctor Bueno (Madrid, Spain)
- Table 2: Adnan Kastrati (Munich, Germany) and Antonio Fernández-Ortíz (Madrid, Spain)
- Table 3: Alex Mebazaa (Paris, France) and José Ramón González Juanatey (Santiago de Compostela, Spain)
- Table 4: Bernard Gersh (Rochester, USA) and Esteban López de Sa (Madrid, Spain)
14:30-16:00 FOCUS ON CARDIOGENIC SHOCK
Chairs: Alessandro Sionis and Roberto Martín Asenjo
- Multiorgan failure in cardiogenic shock.
Alex Mebazaa (Paris, France) - Coronary revascularization.
Uwe Zeymer Ludwigshafen am Rhein, (Germany) - VADs: tell us when, which and how.
Susanna Price (London, UK)
16:00-17:00 UPDATE IV
Interactive debate with the experts: New evidence in dyslipidemia treatment
Chair:
New evidence in dyslipidemia treatment
José Ramón González-Juanatey
Experts panel:
José Tuñón (Madrid, Spain)
Lluís Masana (Tarragona, Spain)
José Luis López Sendón (Madrid, Spain)
- In which patients should we use a PCSK9i?
- PCSK9i: always after ezetimibe?
- LDL-c control: the earlier the better?
17:00-17:30 Coffee break 17:30-18:30 NEW INSIGHTS IN ACUTE AORTIC SYNDROMES
Chairs: Alberto Forteza and Rosa-Maria Lidón
- The 10 main lessons from 20-year of clinical collaborative research (IRAD and RESA registries).
Arturo Evangelista (Barcelona, Spain) - How can we optimize surgical treatment results in type A AAS?
Martin Grabenwöger (Vienna, Austria) - When medical treatment is not enough in type B acute aortic syndrome?
Christophe Nienaber (London, UK)
18:30-20:00 SECONDARY PREVENTION AND MANAGEMENT IN STABLE CORONARY ARTERY DISEASE
Chairs: José Ramón González Juanatey and Esteban López de Sa
- What is residual risk and what can I do to reduce it?
Joao Morais (Leiria, Portugal) - Stable coronary artery disease 2018: current role of medical treatment and revascularistation.
José Luis López Sendón (Madrid, Spain) - Dyslipidemia.
Antonio J. Vallejo-Vaz (London, UK) - Diabetes and ischemic heart disease. Challenges in 2018.
Aldo Pietro Maggioni (Milan, Italy)
- STEMI.
-
09:00-10:00 ROUND TABLE ON ANTITHROMBOTIC TREATMENT
Chairs: Inmaculada Roldán and José Luis Ferreiro
- Individualizing duration of dual antiplatelet therapy in ACS patients undergoing coronary stenting: a practical approach beyond the scores.
Giuseppe Biondi-Zoccai (Roma, Italy) - Management of antithrombotic therapy in acute coronary syndrome patients with atrial fibrillation undergoing percutaneous coronary intervention.
Felicita Andreotti (Roma, Italy) - New antithrombotic strategies in ACS: de-escalation of P2Y12 inhibitors, dual therapy with rivaroxaban, ticagrelor monotherapy.
Dominick Angiolillo (Jacksonville, USA)
10:00-11:00 UPDATE V
Discussion Table:
CardioFighters : Key questions in secondary prevention, hypercholesterolemia and ischemic heart disease.
Referee: Almudena Castro (Madrid, Spain)
CardioFighters:
Juan Cosín Sales (Valencia, Spain)
Carlos Escobar Cervantes (Madrid, Spain)11:00-11:30 Coffee break 11:30-12:30 BIOMARKERS: 25 years of troponin
Chairs: Josep Masip and Jordi Ordoñez
- "Biomarkers and coronary syndromes. A long and fruitful relationship".
Jordi Ordoñez (Barcelona, Spain) - “Evolution in the diagnosis of the acute coronary syndrome”.
Nick Mills (Edinburgh, Scothland) - “High-sensitivity cardiac troponins as biomarkers of stable cardiac ischemic disease”.
Christian Mueller (Basel, Switzerland)
12:30.13:30 “CASE WARS”: CARDIOLOGY TRAINEES PRESENT THEIR MOST CHALLENGING CLINICAL CASES.
Chairs: Ivan Nuñez and José Barrabés
- Cardiogenic shock after STEMI due to embolia. Role of mechanical circulatory support.
Inés Toranzo (Santander, Spain) - Cardiac arrest: When therapeutic hypothermia reveals the mechanism
Maria Isabel Barrionuevo (Albacete, España)
Nick Mills (Edinburgh, Scothland)
Joao Morais (Leiria, Portugal)
Christian Mueller (Basel, Switzerland)13:30 CLOSING CEREMONY - Individualizing duration of dual antiplatelet therapy in ACS patients undergoing coronary stenting: a practical approach beyond the scores.
